Wells Fargo cuts CRISPR Therapeutics stock price target on earnings
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report does not map to a usual set of affected companies.
Directly affected
- WFC Wells Fargo+4.4% 30d
Named in this report.
- CRSP CRISPR Therapeutics AG-14.3% 30d
Named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that CRISPR Therapeutics AG belongs to, so it often moves with news about it.
- BNTX BioNTech SE-9.3% 14d
BioNTech SE is a peer of CRISPR Therapeutics AG in biological products, (no diagnostic substances); rivals often move on the same news.
- NBIX Neurocrine Biosciences
Neurocrine Biosciences is a peer of CRISPR Therapeutics AG in biological products, (no diagnostic substances); rivals often move on the same news.
- QGEN Qiagen N.V
Qiagen N.V is a peer of CRISPR Therapeutics AG in biological products, (no diagnostic substances); rivals often move on the same news.
- AMGN Amgen+13.5% 30d
Amgen is a peer of CRISPR Therapeutics AG in biological products, (no diagnostic substances); rivals often move on the same news.
- GILD Gilead Sciences+13.4% 30d
Gilead Sciences is a peer of CRISPR Therapeutics AG in biological products, (no diagnostic substances); rivals often move on the same news.
- XLF Financial Select Sector SPDR-1.6% 30d
Financial Select Sector SPDR holds the financials sector that Wells Fargo belongs to, so it often moves with news about it.
- JPM JPMorgan Chase+0.1% 30d
JPMorgan Chase is a peer of Wells Fargo in national commercial banks; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| WFC | -2.11% | -2.46% | base | after close | after close | after close | after close |
| CRSP | +8.14% | +2.77% | base | after close | after close | after close | after close |
| XLV | -2.31% | +0.48% | base | after close | after close | after close | after close |
| BNTX | +1.32% | +1.48% | base | after close | after close | after close | after close |
| NBIX | -11.66% | -11.28% | base | after close | after close | after close | after close |
| QGEN | -0.09% | -0.33% | base | after close | after close | after close | after close |
| AMGN | -2.03% | +1.07% | base | after close | after close | after close | after close |
| GILD | -4.93% | +2.07% | base | after close | after close | after close | after close |
| XLF | -1.85% | -1.14% | base | after close | after close | after close | after close |
| JPM | +0.41% | -0.26% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Wells Fargo cuts CRISPR Therapeutics stock price target on earnings Investing.com
Source: Investing.com
This story
| Company | When | Move | Status |
|---|---|---|---|
| AMGN | three days earlier | +1.07% | final price |
| AMGN | five days earlier | -2.03% | final price |
| BNTX | three days earlier | +1.48% | final price |
| BNTX | five days earlier | +1.32% | final price |
| CRSP | three days earlier | +2.77% | final price |
| CRSP | five days earlier | +8.14% | final price |
| GILD | three days earlier | +2.07% | final price |
| GILD | five days earlier | -4.93% | final price |
| JPM | three days earlier | -0.26% | final price |
| JPM | five days earlier | +0.41% | final price |
| NBIX | three days earlier | -11.28% | final price |
| NBIX | five days earlier | -11.66% | final price |
| QGEN | three days earlier | -0.33% | final price |
| QGEN | five days earlier | -0.09% | final price |
| WFC | three days earlier | -2.46% | final price |
| WFC | five days earlier | -2.11% | final price |
| XLF | three days earlier | -1.14% | final price |
| XLF | five days earlier | -1.85% | final price |
| XLV | three days earlier | +0.48% | final price |
| XLV | five days earlier | -2.31% | final price |
Congressional trades in the stocks in this story
- Rep. Rohit Khanna bought Wells Fargo (WFC) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 40 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Wells Fargo (WFC) (held by a dependent child), worth $15,001 - $50,000 on 17 Sep 2026. That is 48 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Wells Fargo (WFC) (held by a dependent child), worth $1,001 - $15,000 on 15 Sep 2026. That is 50 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. David J. Taylor bought Amgen (AMGN), worth $1,001 - $15,000 on 22 Sep 2026. That is 43 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. David J. Taylor sold Amgen (AMGN), worth $1,001 - $15,000 on 26 Aug 2026. That is 70 days before publication. Filed 5 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Amgen (AMGN) (held by a spouse), worth $1,001 - $15,000 on 12 Aug 2026. That is 84 days before publication. Filed 2 Sep 2026. View the filing.
- Rep. Rohit Khanna sold Gilead Sciences (GILD) (held by a dependent child), worth $1,001 - $15,000 on 10 Aug 2026. That is 86 days before publication. Filed 4 Sep 2026. View the filing.
- Sen. Sheldon Whitehouse sold Jpmorgan Chase (JPM) (held by a spouse), worth $15,001 - $50,000 on 4 Sep 2026. That is 61 days before publication. Filed 1 Oct 2026. View the filing.
- Sen. Sheldon Whitehouse sold Jpmorgan Chase (JPM), worth $15,001 - $50,000 on 4 Sep 2026. That is 61 days before publication. Filed 1 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Jpmorgan Chase (JPM) (held by a spouse), worth $100,001 - $250,000 on 27 Aug 2026. That is 69 days before publication. Filed 4 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Wells Fargo cuts CRISPR Therapeutics stock price target on earnings” scores 12 out of 100. The score uses 1 sources.